As of 2025-07-05, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -4.63 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.19 USD, the upside of Sana Biotechnology Inc is -245.01%.
Based on its market price of 3.19 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 245.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.63 - -4.63 | -4.63 | -245.01% |
| P/E | (12.45) - (17.60) | (12.67) | -497.3% |
| DDM - Stable | (6.29) - (17.47) | (11.88) | -472.4% |
| DDM - Multi | (6.87) - (15.30) | (9.53) | -398.8% |
| Market Cap (mil) | 719.54 |
| Beta | 0.57 |
| Outstanding shares (mil) | 225.56 |
| Enterprise Value (mil) | 623.41 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.53% |
| Cost of Debt | 5.00% |
| WACC | 7.60% |